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Objectives: To compare the accuracy of Light’s criteria for categorizing a pleural effusion as an exudate with several 
alternative criteria. 
Design: Prospective evaluation of patients who underwent a diagnostic thoracocentesis. 
Setting: Community teaching hospital in Lleida, Spain. 
Patients and methods: Medical records and pleural fluid characteristics of 241 consecutive patients with pleural 
effusion admitted over a 29-month period were reviewed. Forty eight of these patients were excluded for different 
reasons. Light’s criteria and a different cutoff level for the pleural fluid cholesterol level kere applied and their 
accuracies were calculated. 
Results: Of the 193 patients included, 38 (20%) had transudates and 155 (80%) exudates. The accuracy of Light’s 
criteria for identifying exudates was 92% [confidence intervals (CI), 88-96%], with a sensitivity of 97% (CI, 94-100%) 
and specificity of 71% (CI, 57X5%). A cutoff level of 50 mg dl- ’ was selected for pleural cholesterol, which yielded 
a sensitivity and specificity of 84% (CI, 79-90%), with an accuracy of 84% (CI, 72-9.6%). Overall, pleural cholesterol 
misclassified more exudates as transudates than Light’s criteria (15 vs. 3.2%, P<O.OOl). The combination of pleural 
cholesterol with lactate dehydroegnase (LDH) or pleural fluid/serum protein ratio revealed a comparable accuracy 
to that achieved with Light’s criteria. 
Conclusions: Light’s criteria are just as useful as the association of pleural cholesterol and LDH to detect exudates. 
In the present study, no parameter, including pleural cholesterol, was superior to Light’s criteria. 
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Introduction 
The initial step in analysing pleural fluid is to ascertain 
whether the effusion is a transudate or an exudate, since 
each one has a distinct differential diagnosis. A transudative 
pleural effusion is caused by a limited number of diseases 
(e.g. heart failure, liver cirrhosis or nephrotic syndrome), 
while an exudative pleural effusion require a more extensive 
diagnostic investigation to establish the cause of this 
alteration (1,2). 
The most commonly used method for differentiating 
exudates from transudates was established by Light et al. 
(3). Fluid is considered exudative if it meets one or more of 
the following: (a) pleural/serum protein ratio greater than 
0.5; (b) pleural/serum lactate dehydrogenase (LDH) ratio 
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greater than 0.6; and (c) absolute pleural LDH level greater 
than two-thirds of the normal upper limit for serum. 
Accuracy for these criteria, calculated from their original 
data, was 99%. However, other authors found poorer 
diagnostic results when applying Light’s criteria, which may 
lead to further unwarranted invasive interventions in up to 
lo-36% of patients with transudates (Lc9). In trying to 
improve specificity, a number of alternative criteria have 
been proposed, which include determination of the pleural 
cholesterol (4,7) or the combination of pleural fluid choles- 
terol and LDH (10-12). Nevertheless, their superiority with 
respect to the criteria of Light et al. (3) is doubtful. The aim 
of this study was to compare the utility of Light’s criteria 
with both the pleural cholesterol, and the result of combin- 
ing cholesterol with every one of the individual indicators of 
Light et al., in order to separate exudates from transudates. 
Material and Methods 
A prospective study of 241 consecutive patients admitted 
for pleural effusions at the authors’ hospital from March 
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1994 to August 1996 was carried out. Forty-eight cases 
were excluded because either no cause was definitely found 
(23 patients), more than one cause was present (18 
patients), or the patients had pulmonary embolism which 
may be accompanied by an exudative or a transudative 
effusion (seven patients). The remaining 193 cases com- 
posed the study group, and they were classified on the basis 
of the following predetermined clinical criteria. 
TABLE 1. Aetiology of 193 pleural effusions 
Causes No. of patients 
Transudates 38 
Congestive heart failure 31 
Liver cirrhosis 5 
Nephrotic syndrome 2 
% 
19.7 
16.1 
3.6 
1.0 
TRANSUDATES 
(a) Congestive heart failure (CHF) was diagnosed when 
there was an enlarged heart with clinical or echocardio- 
graphic evidence of cardiac dysfunction, and one or more 
of the following alterations: pulmonary venous congestion 
on radiography, peripheral edema, response to optimal 
medical treatment, and an absence of malignancy, respirat- 
ory infection or pulmonary emboli. 
(b) Liver cirrhosis was diagnosed by clinical and labora- 
tory evidence of hepatic damage with portal hypertension 
Exudates 155 80.3 
Neoplastic 60 31.1 
Parapneumonic 51 26.4 
Tuberculosis 26 13.5 
Other exudates* 18 9.3 
*Postsurgery, 6; subphrenic abscess, 3; Dressler’s syn- 
drome, 2; pancreatitis, 2; pleuropericarditis, 1; sarcoidosis, 
1; systemic lupus erythematosus, 1; traumatic, 1; Wegener’s 
granulomatosis, 1. 
or hypoalbuminaemia. 
(c) Nephrotic syndrome was diagnosed in presence of 
proteinuria greater than 3.5 g day- i, oedema and 
hypoalbuminaemia (less than 3.5 mg dl - ‘). 
laboratory, the upper normal limit for LDH serum level is 
460 IU 1~ ‘. The cholesterol concentration (mg dl - ‘) was 
determined by the CHOD-PAP enzymatic-colourimetric 
technique (13). In addition, blood samples were drawn on 
the same day for protein and LDH measurements. 
EXUDATES 
(a) Malignant effusions were identified by pleural biopsy 
specimen or pleural fluid cytopathologic study, or by exclu- 
sion of any other cause of pleural effusion in a patient 
with a histologically proved primary malignancy as 
well as documented intrathoracic involvement by imaging 
techniques. 
(b) Tuberculosis was diagnosed by isolation of Mycobac- 
terium tuberculosis by culture of pleural fluid or tissue, or a 
pleural biopsy showing typical caseating granulomas. When 
a pleural biopsy was not done, patients were considered to 
have tuberculous pleurisy if they met the following three 
conditions: (i) adenosine deaminase (ADA) level in pleural 
fluid greater than 45 U 1 and/or isolation of M. tuberculosis 
from sputum; (ii) exclusion of any other cause known to be 
associated with pleural effusion; and (iii) the effusion 
cleared in response to antituberculous therapy. 
(c) Parapneumonic effusions were diagnosed by the pres- 
ence of an acute febrile illness with purulent sputum, 
pulmonary infiltrates and responsiveness to antibiotic treat- 
ment, or identification of the organism in the pleural fluid. 
(d) Other exudates were effusions clearly secondary to 
trauma, intra-abdominal inflammatory processes, uraemia, 
Dressler’s syndrome, or collagen vascular disease. In all 
cases, any other cause of pleural effusion was excluded. 
Pleural fluid samples obtained by thoracocentesis under- 
went biochemical, cytological and microbiological analysis. 
A selected discrete multichannel analyser (Hitachi 717) was 
used to examine biochemical parameters. Total protein 
concentrations (g dl - ‘) were assayed using the biuret 
method. The LDH value (IU l- ‘) was estimated by a 
kinetic ultraviolet optimized standard method, using a 
specific kit (Boehringer Mannheim). In the authors’ 
STATISTICAL ANALYSIS 
For each parameter and their different combinations, the 
following statistics were evaluated: sensitivity, specificity 
and accuracy to diagnose exudative pleural effusions. These 
indices were compared using McNemar’s exact test for 
correlated proportions. Bidirectional P values were used, 
and PcO.05 was considered significant. Quantitative data 
are reported as mean * 1 SD and accuracies are given with a 
confidence interval (CI) of 95%. 
Results 
The 193 patients studied consisted of 72 women and 121 
men with a mean age of 61 5 19 years (range, 15-95 years). 
Among the 38 patients (20%) with transudates, 15 were 
women and 23 were men, with a mean age of 74 + 8 years 
(range, 53-95 years). Among the 155 patients (80%) with 
exudates, 57 were women and 98 were men, with a mean 
age of 57 f 18 years (range, 15-87 years). The causes of the 
193 effusions are listed in Table 1. Applying the criteria of 
Light et al., 177 of the patients were correctly classified 
(accuracy, 92%. CI 88-96%). Five of the 155 exudates 
(3.2%) were misclassified as transudates (sensitivity 97%, 
CI, 94-100%) and 11 of the 38 transudates (29%) as 
exudates (specificity 71%, CI, 57X35%). The five misclassi- 
fied exudates consisted of three patients with malignancy 
and two parapneumonic effusions. All erroneously classi- 
fied transudates were secondary to congestive heart failure 
(CHF), of which nine patients (82%) had previously 
received diuretics instead of 16 (59%) of 27 correctly 
classified (PcO.005). 
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TABLE 2. Usefulness of differents cutoff level for cholesterol 
pleural in diagnosing exudates 
Cholesterol pleural Sensitivity Specificity Accuracy 
(mg dl-’ (%I (%I (%I 
35 89 63 84 
40 88 71 84 
45 86 76 84 
50 84* 841- 841 
55 80 87 81 
60 79 92 81 
65 71 92 75 
70 62 95 68 
*Significantly higher than cholesterol 55 or 60 mg dl~ ’ 
(P~O~OO5). 
tNo significant differences with cholesterol 40, 45, 55 or 
60mgdl-‘. 
$No significant differences with cholesterol 40 or 45 mg dl. 
To maximize sensitivity over specificity in the diagnosis 
of an exudative effusion, different cutoff levels for choles- 
terol were applied as shown in Table 2. The pleural 
cholesterol value that best differentiated between transu- 
dates and exudates was 50 mg dl~ ’ (sensitivity 84%, CI, 
79-90%; and specificity of 84%, CI, 72-96%). The 24 
exudates (15%) that were misclassified consisted of nine 
neoplasic, 10 parapneumonic one tuberculosis, two postsur- 
gery and 2 subphrenic abscess. On the contrary, 11 transu- 
dates erroneously labelled as exudates consisted of CHF. Of 
the 11 transudates misclassified by the criteria of Light 
et al., seven were correctly classified though cholesterol 
level, but another two correctly identified by the former 
criteria were misclassified by the latter. On the other hand, 
19 of the 24 exudates misdiagnosed with cholesterol pleural 
were correctly classified with Light’s criteria. Table 3 details 
the sensitivity, specificity and accuracy, for the criteria of 
Light et al., cholesterol pleural, both parameters combined, 
and all the possible combinations of cholesterol and the 
individual components of Light’s criteria. As shown, the 
criteria of Light et al. revealed best accuracy (P<O.OOl) and 
sensitivity (P<O.OOl) than cholesterol 50 mg dl - ‘. No sig- 
nificant advantages were found combining cholesterol with 
the criteria of Light et al. or with any of the other 
parameters evaluated. 
Discussion 
In this study the criteria of Light et al. have been shown to 
be not as satisfactory as reported originally (3). However, 
they were highly sensitive (97%) for exudates, the specificity 
being much lower (71%) but not improved for other par- 
ameters at the present study. Of specific concern is that the 
present data suggest that prior diuretic treatment may 
explain this low specificity. Chakko et al. (14) believe that 
chronic diuretic therapy in CHF causes significant changes 
in the pleural fluid’s chemistry, and in some cases, trans- 
formed transudates to exudates. However, Shinto and 
Light (15) reported that it is uncommon in fluid samples 
obtained 48 h after the initiation of diuretics. 
Light’s criteria maximize sensitivity over specificity in the 
diagnosis of an exudate. In fact, it is better to occasionally 
misdiagnose a transudate as an exudate than it is to 
mistakenly characterize an exudate as a transudate. In an 
effort to improve the accuracy of the criteria of Light et al., 
Romero et al. (8) have proposed their modification by the 
adoption of new cutoff points for the biochemical analyses. 
However, in a recent study by the present authors (16) 
advantages of this change were not observed. 
Ham et al. (4) reported that cholesterol level was superior 
to Light’s criteria in distinguishing transudates from exu- 
dates. The application of a cutoff of 60 mg dl- ’ yielded a 
sensitivity and specificity of 90 and lOO%, respectively. 
ValdCs et al. (5) later confirmed this results, adopting a 
cutoff point of 55 mg dl-’ (sensitivity 91%, specificity 
TABLE 3. Sensitivity, specificity and accuracy for the diagnosis of an exudate according to different 
parameters 
Sensitivity Specificity Accuracy 
% (CI) % (CI) % W) 
Light’s criteria 97 (94-100) 71 (57-85) 92 (88-96) 
Pr PIS 10.5 86 (80-91) 84 (72-96) 86 (81-91) 
LDH P/S ~0.6 90 (85-95) 82 (70-94) 89 (85-93) 
LDH pleural >2/3 LDH serum 82 (78-86) 89 (79-99) 83 (78-88) 
Cholesrerol >50 mg dl - ’ 84 (79-90) 84 (72-96) 84 (79-90) 
Cholesterol* + Light’s criteria 97 (94-100) 66 (51-81) 91 (87-95) 
Cholesterol* +Pr P/S* >0.5 87 (82-92) 80 (67-93) 83 (78-88) 
Cholesterol* + LDH P/S? ~0.6 95 (92-98) 72 (58-86) 88 (83-93) 
Cholesterol* +LDH pleural >307 IU l- ’ 95 (92-98) 76 (62-90) 88 (83-93) 
Pr P/S, protein pleural/serum; LDH P/S, lactate dehydrogenase pleural/serum; *cholesterol 
250 mg dl-‘. 
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100%). The present authors, in accordance with others 
authors (89) found pleural cholesterol to be a poorer 
method than the criteria of Light et al. Thus, applying the 
best cutoff level (50 mg dl - ‘), a sensitivity, specificity and 
accuracy of 84% was found. Using lower cutoff levels 
(40 mg dl - ‘) yielded a sensitivity (88%) significantly lower 
than Light’s criteria (P<O.O05) with the same specificity 
(71%). The reason for the discrepancy between different 
studies is unknown. 
In addition to cholesterol, other parameters have been 
proposed to distinguish between pleural transudates and 
exudates. For example, Sanchez et al. (10) proposed the 
combination of cholesterol and pleural LDH, and found an 
accuracy similar to the criteria of Light et al. with the 
advantage of requiring only two laboratory determinations 
and no contemporary blood analyses. Their finding, later 
confirmed by Costa et al. (11) who found 99% sensitivity 
and 98% specificity. The present results show that all the 
possible the combinations of cholesterol (50 mg dl - ‘) with 
the individual components of Light’s criteria, only the 
association of cholesterol with either LDH pleural or 
pleural fluid/serum LDH ratio yields similar sensitivity 
(P>O.6), specificity (P>O.6) and accuracy (P>O.3) as the 
criteria of Light et al. However, pleural cholesterol is not 
standardized and the best cutoff level for cholesterol pleural 
should be attained for each particular laboratory before 
introducing it in routine work-up. 
It is concluded that Light’s criteria and the association of 
LDH and cholesterol pleural are equally effective in distin- 
guishing between pleural exudates and transudates. At the 
present time, no parameters have been superior to the 
criteria of Light et al. which remain the most clinically 
useful and accurate diagnostic standard available. In the 
authors’ opinion, it is time to accept the fact that Light’s 
criteria are as good as they are going to get, and 
to concentrate on newer and more specific tests for the 
diagnosis of exudates. 
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